Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Tulpule

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Current Opinion in Oncology|August 12, 2005
Multidrug resistance in AIDS-related lymphomaAnil Tulpule
Expert Opinion on Pharmacotherapy|June 17, 2009
Bendamustine therapy in chronic lymphocytic leukemiaDavid Masiello, Anil Tulpule
Cancer|March 29, 2002
Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infectionAlexandra M Levine, Saeed Sadeghi, Byron Espina, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 7, 2017
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinibDavid J Hermel, Victor Chiu, Melody H Hermel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapySoon-Thye Lim, Roksana Karim, Anil Tulpule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2005
AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapySoon Thye Lim, Roksana Karim, Bharat N Nathwani, et al.
Blood|October 9, 2004
Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endotheliumRizwan Masood, Guangbin Xia, D Lynne Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study TeamAriela Noy, David T Scadden, Jeannette Lee, et al.
Cancer|September 16, 2006
Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignanciesDavid J Straus, Marcia A Testa, Brenda J Sarokhan, et al.
Investigational New Drugs|January 7, 2004
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II studyAnil Tulpule, Byron M Espina, A B Pedro Santabarbara, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Current Opinion in Oncology|August 12, 2005
Multidrug resistance in AIDS-related lymphomaAnil Tulpule
Expert Opinion on Pharmacotherapy|June 17, 2009
Bendamustine therapy in chronic lymphocytic leukemiaDavid Masiello, Anil Tulpule
Cancer|March 29, 2002
Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infectionAlexandra M Levine, Saeed Sadeghi, Byron Espina, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 7, 2017
Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinibDavid J Hermel, Victor Chiu, Melody H Hermel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2005
Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapySoon-Thye Lim, Roksana Karim, Anil Tulpule, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2005
AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapySoon Thye Lim, Roksana Karim, Bharat N Nathwani, et al.
Blood|October 9, 2004
Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endotheliumRizwan Masood, Guangbin Xia, D Lynne Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2004
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study TeamAriela Noy, David T Scadden, Jeannette Lee, et al.
Cancer|September 16, 2006
Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignanciesDavid J Straus, Marcia A Testa, Brenda J Sarokhan, et al.
Investigational New Drugs|January 7, 2004
Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II studyAnil Tulpule, Byron M Espina, A B Pedro Santabarbara, et al.
Pageof 3